Daniel Merk
Goethe-Universität Frankfurt am Main
H-index: 30
Europe-Germany
Top articles of Daniel Merk
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties | Journal of Medicinal Chemistry | Max Lewandowski Melania Carmina Loris Knümann Minh Sai Sabine Willems | 2024/1/18 |
Dual soluble epoxide hydrolase inhibitor–farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis | Frontiers in Immunology | Md Abdul Hye Khan Benjamin Nolan Anna Stavniichuk Daniel Merk John D Imig | 2024/1/3 |
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma | Journal of Experimental & Clinical Cancer Research | Bianca Walter Sophie Hirsch Laurence Kuhlburger Aaron Stahl Leonard Schnabel | 2024/12 |
Rational design and virtual screening identify mimetics of the RXR agonist valerenic acid | ChemMedChem | Laura Isigkeit Annette Kärcher Gustave Adouvi Silvia Arifi Daniel Merk | 2024/1/18 |
A Fluorescence-Based Reporter Gene Assay to Characterize Nuclear Receptor Modulators | Espen Schallmayer Daniel Merk | 2023/8/10 | |
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system | Neuro-Oncology Advances | Mirjam Renovanz Sylvia C Kurz Johannes Rieger Bianca Walter Hannes Becker | 2023/1/1 |
Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer Agonism | ChemMedChem | Daniel Zaienne Laura Isigkeit Julian A Marschner Silke Duensing‐Kropp Georg Höfner | 2023/11/2 |
De Novo Design of Nurr1 Agonists via Fragment-Augmented Generative Deep Learning in Low-Data Regime | Journal of Medicinal Chemistry | Marco Ballarotto Sabine Willems Tanja Stiller Felix Nawa Julian A Marschner | 2023/5/31 |
Check for updates | Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries: 8th International Workshop, BrainLes 2022, Held in Conjunction with MICCAI 2022, Singapore, September 18, 2022, Revised Selected Papers | Segmentation Framework via Optimal Mass Transportation Pre-processing Jia-Wei Liao¹ Tsung-Ming Huang Tiexiang Li | 2023/7/17 |
An Introduction to Chemogenomics | Apirat Chaikuad Daniel Merk | 2023/8/10 | |
State-of-the-art methodological investigation of carotenoid activity and metabolism–from organic synthesis via metabolism to biological activity–exemplified by a novel retinoid … | Torsten Bohn Angel R de Lera Jean-Francois Landrier Harald Carlsen Daniel Merk | 2023 | |
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand Dihydroxyindole | Journal of Medicinal Chemistry | Minh Sai Jan Vietor Moritz Kornmayer Markus Egner Úrsula López-García | 2023/9/26 |
Illuminating the druggable genome through patent bioactivity data | PeerJ | Maria P Magariños Anna Gaulton Eloy Félix Tevfik Kiziloren Ricardo Arcila | 2023/5/2 |
Check Chapter 3 updates | Xylem: Methods and Protocols | Alex Tavkhelidze Gerhard Buck-Sorlin Winfried Kurth | 2023/10/28 |
Compilation of Custom Compound/Bioactivity Datasets from Public Repositories | Laura Isigkeit Daniel Merk | 2023/8/10 | |
Development of a Potent Nurr1 Agonist Tool for in Vivo Applications | Journal of Medicinal Chemistry | Jan Vietor Christian Gege Tanja Stiller Romy Busch Espen Schallmayer | 2023/4/26 |
Deep interactome learning for de novo drug design | Kenneth Atz Leandro Cotos Muñoz Clemens Isert Maria Håkansson Dorota Focht | 2023/9/19 | |
Light-controlled inhibition of the circadian regulator RORγ | Martin Reynders Sabine Willems Julian A Marschner Thomas Wein Daniel Merk | 2023/7/31 | |
Structure-guided design of a highly potent RXR agonist with superior physicochemical properties | Max Lewandowski Melania Carmina Loris Knümann Minh Sai Sabine Willems | 2023/12/12 | |
P10. 25. A ATR INHIBITION IN EXPERIMENTAL GLIOMA: DISCOVERY AND VALIDATION OF MOLECULAR TARGETS FOR FUNCTIONALLY-INSTRUCTED COMBINATION THERAPIES | Neuro-Oncology | B Walter S Hirsch L Kuhlburger A Stahl L Schnabel | 2023/9/1 |
